Cannabinoids Improve Gastrointestinal Symptoms in a Parenteral Nutrition–Dependent Patient With Chronic Intestinal Pseudo‐Obstruction
Authors:
- 17 March 2020
- journal article
- case report
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 45 (2) , 427-429
Abstract
Chronic intestinal pseudo‐obstruction (CIPO) is a rare and challenging cause of pediatric intestinal failure, requiring long‐term parenteral nutrition in most cases. Despite optimal management, some patients experience chronic abdominal pain and recurrent obstructive episodes with a major impact on their quality of life. Cannabinoids have been successfully used in some conditions. However, their use in CIPO has never been reported in the literature. We report a case of successful use of medicinal cannabinoids in a patient with CIPO, resulting in a significant reduction of abdominal pain, vomiting, and subocclusive episodes and increased appetite and weight, without major adverse events. Although further observations are required to consolidate these findings, this case may be helpful for other patients suffering from the same condition.Keywords
This publication has 7 references indexed in Scilit:
- Multiple intestinal intussusceptions caused by highly impaired gastrointestinal motility in a patient with chronic cannabis consumptionJournal of Surgical Case Reports, 2019
- Paediatric Intestinal Pseudo‐obstructionJournal of Pediatric Gastroenterology and Nutrition, 2018
- Cannabinoids and gastrointestinal motility: Pharmacology, clinical effects, and potential therapeutics in humansNeurogastroenterology & Motility, 2018
- Medical Cannabinoids in Children and Adolescents: A Systematic ReviewPediatrics, 2017
- The Effects of Cannabis Among Adults With Chronic Pain and an Overview of General HarmsAnnals of Internal Medicine, 2017
- Role of cannabis in digestive disordersEuropean Journal of Gastroenterology & Hepatology, 2017
- Cannabinoids for Medical UseJAMA, 2015